tirzepatide news september 27 2025 Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for ๐ฃ BIG NEWS IN OBESITY
Description
[10] Semaglutide was initially approved by the US Food and Drug Administration in 2017 for the treatment of type 2 diabetes
Popular targets include Type 1 and Type 2 Diabetes Mellitus, PCOS, CKD, and MASH
Vendrell J, El Bekay R, Peral B, Garcia-Fuentes E, Megia A, Macias-Gonzalez M, et al
And not just for your clients, but for you, too
The broader GLP-1 class literature -- and the Phase 2 retatrutide data specifically -- documents that weight regain is common after discontinuation
52.8 years)
